The nurse is preparing to administer a first dose of ado-trastuzumab emtansine [Kadcyla] to a patient who has metastatic breast cancer. Which nursing action is correct?

Question

Quizplus · Accepted Answer

Ado-trastuzumab emtansine is used for patients with HER2-positive disease. Although severe hypersensitivity reactions may occur, it is not recommended that a test dose along with an antihistamine be given. The initial dose should be given over 90 minutes, with subsequent doses given over 30 minutes if tolerated. Liver damage is common, so liver function needs to be monitored.

The Nurse Is Preparing to Administer a First Dose of Ado-Trastuzumab